First-quarter net sales were 62,590 million yen, up 1.9% YoY. Operating income 2,099 million yen, ordinary income 2,137 million yen, net income attributable to owners of parent 1,574 million yen. By segment, clinical diagnostics grew in sales, examinations and related services improved profitability, and healthcare declined in sales and profit. Full-year forecast unchanged. Due to treasury stock acquisition, equity ratio declined to 51.1%.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4544","jir_company_name":"H.U. Group Holdings, Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-12","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/4544-20260812-01.pdf","jir_short_summary":"First-quarter net sales were 62,590 million yen, up 1.9% YoY. Operating income 2,099 million yen, ordinary income 2,137 million yen, net income attributable to owners of parent 1,574 million yen. By segment, clinical diagnostics grew in sales, examinations and related services improved profitability, and healthcare declined in sales and profit. Full-year forecast unchanged. Due to treasury stock acquisition, equity ratio declined to 51.1%.","jir_summary":"### Overview of performance\nTotal net sales for this quarter were 62,590 million yen, supported by growth in the clinical diagnostics business, including currency effects, and pricing normalization in examinations and related services, achieving higher sales. Operating income was 2,099 million yen and ordinary income 2,137 million yen, turning profitable. By segment, clinical diagnostics remained solid, examinations and related services grew in sales and reduced fixed costs to stay profitable. Healthcare-related services declined in sales and profit due to the impact of stock transfers. The full-year forecast remains unchanged.\n\n### Financial position and outlook\nTotal assets at the end of the first quarter were 263,004 million yen, net assets 134,644 million yen, and equity ratio 51.1%. Cash and cash equivalents decreased, but cash flow from operations amounted to 2,889 million yen. Meanwhile, net assets decreased due to treasury stock acquisition and dividend payments. The full-year earnings guidance remains as announced.","jir_financial_highlights":"Net sales: 62,590 (YoY +1.9%)\nOperating income: 2,099 (YoY +141.1% increase)\nOrdinary income: 2,137 (YoY \u25b3 none (compared with the previous year's first quarter ordinary loss))\nNet income attributable to owners of parent: 1,574 (YoY moved to surplus (previous year \u25b31,197))\nEquity ratio: 51.1% (down 0.2 percentage points from the previous period)","jir_category":"","jir_hashtags":"#H.U.Group Holdings, #FinancialResults, #MidTermPlan","jir_key_figures":"Net sales: 62,590 million yen (YoY +1.9%)\nOperating income: 2,099 million yen (YoY +141.1%)\nOrdinary income: 2,137 million yen\nNet income attributable to owners of parent: 1,574 million yen\nEquity ratio: 51.1% (vs prior year -0.2%)","jir_meta_title":"H.U. Group Holdings \u2014 First Quarter of FY2027 Financial Results | Net Sales 62,590 million yen, Operating Income 2,099 million yen","jir_meta_description":"Summary of H.U. Group Holdings' first quarter financial results for the fiscal year ending March 2027. Includes trends by segment, confirmation of full-year guidance, and financial position in concise form.","jir_og_title":"H.U. Group Holdings | Q1 Financial Results","jir_og_description":"Summary of H.U. Group Holdings' quarterly results. Brief overview of revenue, profit trends, segment contributions, and financial position.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Sales Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2026Q1\\\",\\\"2026Q2\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[62590,0],\\\"borderColor\\\":\\\"#3e95cd\\\",\\\"fill\\\":false}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2026Q1\\\",\\\"2026Q2\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[2099,0],\\\"borderColor\\\":\\\"#8e5ea2\\\",\\\"fill\\\":false}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Net Sales\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Clinical Diagnostics\\\",\\\"Examinations & Related Services\\\",\\\"Healthcare-Related Services\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[16386,39603,6600],\\\"backgroundColor\\\":[\\\"#4e79a7\\\",\\\"#f28e2b\\\",\\\"#e15759\\\"]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Operating Income\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Clinical Diagnostics\\\",\\\"Examinations & Related Services\\\",\\\"Healthcare-Related Services\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[2438,674,520],\\\"backgroundColor\\\":[\\\"#4e79a7\\\",\\\"#f28e2b\\\",\\\"#e15759\\\"]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"table\", \"jir_chart_title\": \"Full-Year Guidance vs Actual\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"table\\\",\\\"data\\\":{\\\"headers\\\":[\\\"Metric\\\",\\\"Full-Year Guidance\\\",\\\"Q1 Actual\\\"],\\\"rows\\\":[[\\\"Net Sales\\\",\\\"256,000\\\",\\\"62,590\\\"],[\\\"Operating Income\\\",\\\"9,000\\\",\\\"2,099\\\"],[\\\"Ordinary Income\\\",\\\"8,000\\\",\\\"2,137\\\"],[\\\"Net Income\\\",\\\"5,000\\\",\\\"1,574\\\"]]},\\\"options\\\":{}}\"}]","ir_related_company":9022,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-101909","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n